COM:GILEAD
Gilead Sciences, Inc.
- Stock
Last Close
89.76
22/11 21:00
Market Cap
85.65B
Beta: -
Volume Today
4.43M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 1.72B - | 1.67B 2.93% | 1.77B 6.02% | 1.19B 32.58% | 807.50M 32.37% | 1.44B 78.39% | 2.54B 76.36% | 2.87B 13.13% | 2.78B 3.38% | ||
average payables | 1.11B - | 1.07B 3.52% | 1.19B 11.77% | 1.01B 15.27% | 802M 20.59% | 751.50M 6.30% | 778.50M 3.59% | 774.50M 0.51% | 805M 3.94% | ||
average receivables | 3.37B - | 5.24B 55.73% | 5.18B 1.15% | 4.18B 19.32% | 3.59B 14.19% | 3.45B 3.75% | 4.24B 22.65% | 4.69B 10.75% | 4.63B 1.23% | ||
book value per share | 10.39 - | 13.06 25.61% | 14.46 10.77% | 15.69 8.47% | 16.59 5.77% | 17.83 7.50% | 14.50 18.72% | 16.77 15.69% | 16.90 0.77% | ||
capex per share | -0.37 - | -0.51 39.42% | -0.56 9.48% | -0.45 19.19% | -0.71 57.70% | -0.65 8.75% | -0.52 20.40% | -0.46 10.85% | -0.58 25.83% | ||
capex to depreciation | -0.53 - | -0.68 28.25% | -0.65 5.05% | -0.46 28.97% | -0.65 40.94% | -0.59 9.12% | -0.44 25.26% | -0.28 35.69% | -0.35 22.57% | ||
capex to operating cash flow | -0.04 - | -0.04 15.44% | -0.04 22.12% | -0.05 10.51% | -0.11 121.83% | -0.09 17.98% | -0.08 11.80% | -0.05 36.09% | -0.08 57.78% | ||
capex to revenue | -0.02 - | -0.02 2.27% | -0.02 7.54% | -0.02 8.18% | -0.04 84.78% | -0.04 11.99% | -0.03 28.36% | -0.02 19.46% | -0.03 25.84% | ||
cash per share | 6.65 - | 9.98 49.94% | 8.88 10.96% | 19.52 119.71% | 23.18 18.77% | 19.17 17.28% | 5.89 69.26% | 5.19 11.92% | 5.09 1.99% | ||
days of inventory on hand | 133.55 - | 178.13 33.38% | 135.94 23.68% | 66.89 50.80% | 61.22 8.47% | 161.38 163.60% | 240.62 49.10% | 151.18 37.17% | 181.95 20.36% | ||
days payables outstanding | 92.02 - | 107.33 16.64% | 103.31 3.75% | 67.97 34.20% | 59.42 12.59% | 55.67 6.31% | 67.38 21.04% | 38.98 42.14% | 58.39 49.79% | ||
days sales outstanding | 67.97 - | 65.46 3.69% | 54.22 17.18% | 53.84 0.69% | 54.88 1.93% | 58.24 6.12% | 72.32 24.18% | 60.06 16.96% | 63.91 6.41% | ||
debt to assets | 0.34 - | 0.41 18.75% | 0.44 7.04% | 0.48 9.04% | 0.43 10.09% | 0.40 7.00% | 0.46 15.03% | 0.39 14.42% | 0.40 1.67% | ||
debt to equity | 0.75 - | 1.11 46.98% | 1.29 16.13% | 1.64 27.04% | 1.27 22.45% | 1.09 14.42% | 1.72 58.72% | 1.27 26.46% | 1.19 6.13% | ||
dividend yield | 0.04 - | 0.01 71.56% | 0.03 102.40% | 0.03 13.92% | 0.04 25.46% | 0.04 6.69% | 0.05 20.63% | 0.04 16.07% | 0.03 12.91% | ||
earnings yield | 0.08 - | 0.12 44.91% | 0.14 15.19% | 0.05 64.90% | 0.07 35.93% | 0.07 2.86% | 0.00 98.14% | 0.07 5,516.54% | 0.04 37.56% | 0.06 31.47% | |
enterprise value | 133.45B - | 135.29B 1.38% | 114.00B 15.74% | 119.59B 4.90% | 90.57B 24.26% | 95.49B 5.43% | 98.64B 3.30% | 112.56B 14.11% | 127.56B 13.33% | ||
enterprise value over ebitda | 8.74 - | 6.05 30.73% | 6.31 4.26% | 8.16 29.35% | 10.20 24.98% | 15.51 52.03% | 11.59 25.28% | 11.90 2.68% | 12.27 3.11% | ||
ev to operating cash flow | 10.41 - | 6.66 36.08% | 6.84 2.77% | 10.05 46.96% | 10.78 7.28% | 10.44 3.15% | 12.08 15.64% | 9.89 18.13% | 14.06 42.21% | ||
ev to sales | 5.36 - | 4.15 22.69% | 3.75 9.50% | 4.58 22.11% | 4.09 10.64% | 4.25 3.91% | 4.00 6.07% | 4.12 3.18% | 4.68 13.43% | ||
free cash flow per share | 8.06 - | 13.38 66.04% | 11.89 11.11% | 8.65 27.24% | 5.76 33.43% | 6.55 13.73% | 5.98 8.69% | 8.60 43.84% | 6.65 22.71% | 6.42 3.51% | |
free cash flow yield | 0.09 - | 0.13 54.67% | 0.17 25.61% | 0.12 27.27% | 0.09 23.75% | 0.10 9.48% | 0.10 1.84% | 0.12 15.41% | 0.08 34.63% | 0.08 2.25% | |
graham net net | -2.99 - | -8.71 191.49% | -16.09 84.70% | -16.05 0.20% | -7.05 56.09% | -8.59 21.81% | -29.91 248.38% | -28.37 5.17% | -24.37 14.10% | ||
graham number | 43.12 - | 60.28 39.79% | 57.28 4.98% | 35.35 38.28% | 39.61 12.04% | 41.25 4.15% | 4.81 88.35% | 43.25 799.92% | 37.30 13.75% | ||
income quality | 1.06 - | 1.12 5.63% | 1.24 10.07% | 2.56 107.31% | 1.54 39.95% | 1.70 10.81% | 91.78 5,283.67% | 1.84 98.00% | 1.99 8.23% | ||
intangibles to total assets | 0.35 - | 0.22 37.64% | 0.18 19.18% | 0.30 69.91% | 0.31 3.09% | 0.29 6.83% | 0.60 107.49% | 0.61 2.02% | 0.59 4.22% | 0 100% | |
interest coverage | 37.05 - | 32.26 12.94% | 18.29 43.29% | 12.63 30.93% | 7.61 39.73% | 4.31 43.41% | 7.14 65.79% | 7.40 3.57% | 7.84 5.96% | -8.06 202.76% | |
interest debt per share | 8.11 - | 14.95 84.26% | 19.34 29.40% | 26.52 37.09% | 21.88 17.50% | 20.15 7.91% | 25.76 27.88% | 22.05 14.41% | 20.85 5.45% | ||
inventory turnover | 2.73 - | 2.05 25.02% | 2.68 31.03% | 5.46 103.24% | 5.96 9.25% | 2.26 62.06% | 1.52 32.93% | 2.41 59.17% | 2.01 16.91% | ||
invested capital | 0.75 - | 1.11 46.98% | 1.29 16.13% | 1.64 27.04% | 1.27 22.45% | 1.09 14.42% | 1.72 58.72% | 1.27 26.46% | 1.19 6.13% | ||
market cap | 143.46B - | 148.14B 3.26% | 95.89B 35.27% | 93.63B 2.35% | 81.19B 13.29% | 82.52B 1.64% | 73.23B 11.26% | 91.20B 24.53% | 107.74B 18.14% | 101.10B 6.16% | |
net current asset value | -1.10B - | 1.29B 217.58% | 867M 32.84% | -8.44B 1,073.01% | -6.49B 23.09% | -7.49B 15.41% | -34.37B 359.00% | -31.83B 7.38% | -26.73B 16.01% | ||
net debt to ebitda | -0.66 - | -0.57 12.32% | 1.00 274.46% | 1.77 76.65% | 1.06 40.35% | 2.11 99.24% | 2.99 41.77% | 2.26 24.35% | 1.91 15.57% | ||
net income per share | 7.95 - | 12.37 55.57% | 10.08 18.48% | 3.54 64.88% | 4.20 18.69% | 4.24 0.91% | 0.07 98.33% | 4.96 6,899.95% | 3.66 26.17% | 4.54 24.06% | |
operating cash flow per share | 8.42 - | 13.89 64.88% | 12.45 10.35% | 9.10 26.87% | 6.47 28.91% | 7.20 11.26% | 6.50 9.75% | 9.06 39.48% | 7.23 20.25% | 6.42 11.26% | |
payables turnover | 3.97 - | 3.40 14.26% | 3.53 3.90% | 5.37 51.98% | 6.14 14.40% | 6.56 6.74% | 5.42 17.38% | 9.36 72.85% | 6.25 33.24% | ||
receivables turnover | 5.37 - | 5.58 3.83% | 6.73 20.75% | 6.78 0.70% | 6.65 1.90% | 6.27 5.77% | 5.05 19.47% | 6.08 20.42% | 5.71 6.03% | ||
research and ddevelopement to revenue | 0.11 - | 0.09 19.47% | 0.17 81.66% | 0.14 14.74% | 0.23 58.56% | 0.41 78.86% | 0.20 49.68% | 0.20 3.77% | 0.18 7.12% | 0.21 15.59% | |
return on tangible assets | 0.54 - | 0.45 17.00% | 0.29 35.65% | 0.09 67.25% | 0.12 31.87% | 0.12 1.05% | 0.00 97.34% | 0.24 7,163.84% | 0.18 25.66% | ||
revenue per share | 16.35 - | 22.29 36.33% | 22.70 1.80% | 19.97 11.99% | 17.05 14.66% | 17.68 3.69% | 19.64 11.12% | 21.74 10.68% | 21.74 0.01% | 21.73 0.05% | |
roe | 0.76 - | 0.95 23.85% | 0.70 26.40% | 0.23 67.62% | 0.25 12.22% | 0.24 6.13% | 0.00 97.95% | 0.30 5,950.35% | 0.22 26.74% | ||
roic | 0.44 - | 0.46 4.06% | 0.31 31.56% | 0.09 71.53% | 0.12 29.57% | 0.09 19.73% | 0.01 92.59% | 0.11 1,562.81% | 0.12 6.20% | ||
sales general and administrative to revenue | 0.12 - | 0.10 12.42% | 0.11 6.52% | 0.15 32.85% | 0.18 23.40% | ||||||
shareholders equity per share | 10.39 - | 13.06 25.61% | 14.46 10.77% | 15.69 8.47% | 16.59 5.77% | 17.83 7.50% | 14.50 18.72% | 16.77 15.69% | 16.90 0.77% | ||
stock based compensation to revenue | 0.01 - | 0.01 19.08% | 0.01 6.84% | 0.02 95.44% | 0.04 56.27% | 0.03 25.81% | 0.03 8.07% | 0.02 10.71% | 0.02 0.40% | ||
tangible asset value | 3.57B - | 7.69B 115.28% | 9.22B 19.83% | -758M 108.22% | 1.68B 321.50% | 4.75B 182.73% | -23.01B 584.79% | -20.72B 9.95% | -16.00B 22.80% | ||
tangible book value per share | 2.35 - | 5.26 123.81% | 6.89 31.02% | -0.58 108.42% | 1.29 323.04% | 3.74 188.96% | -18.31 589.80% | -16.50 9.88% | -12.75 22.73% | ||
working capital | 12.13B - | 24.13B 98.91% | 29.26B 21.29% | 29.71B 1.53% | 25.05B 15.69% | 21.73B 13.25% | 4.42B 79.66% | 3.45B 22.02% | 3.99B 15.79% |
All numbers in USD (except ratios and percentages)